919
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964–2003 followed up to the end of 2006

, , , , , & show all
Pages 655-664 | Received 17 Nov 2009, Accepted 18 Dec 2009, Published online: 16 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Kristina Laugesen, Jonas F Ludvigsson, Morten Schmidt, Mika Gissler, Unnur Anna Valdimarsdottir, Astrid Lunde & Henrik Toft Sørensen. (2021) Nordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries. Clinical Epidemiology 13, pages 533-554.
Read now
Kaire Innos, Teesi Sepp, Aleksei Baburin, Andres Kotsar, Katrin Lang, Peeter Padrik & Tiiu Aareleid. (2019) Increasing kidney cancer incidence and survival in Estonia: role of age and stage. Acta Oncologica 58:1, pages 21-28.
Read now
Astrid Christine Petersen, Mette Søgaard, Frank Mehnert, Erik Højkjær Larsen, Frede Donskov, Nessn H Azawi & Bjarne Kromann-Andersen. (2016) The database of the Danish Renal Cancer Group. Clinical Epidemiology 8, pages 725-729.
Read now
Thor Knak Jensen, Niels Viggo Jensen, Simon Møller Jørgensen, Peter Clark & Lars Lund. (2016) Trends in cancer of the urinary bladder and urinary tract in elderly in Denmark, 2008–2012. Acta Oncologica 55:sup1, pages 85-90.
Read now
Martin Andreas Røder, Klaus Brasso, Ea Rusch, Jørgen Johansen, Niels Christian Langkilde, Helle Hvarness, Steen Carlsson, Henrik Jakobsen, Michael Borre & Peter Iversen. (2015) Length of life gained with surgical treatment of prostate cancer: A population-based analysis. Scandinavian Journal of Urology 49:4, pages 275-281.
Read now
David Lyrdal, Frank Aldenborg, Erik Holmberg, Ralph Peeker & Sven Lundstam. (2013) Kidney cancer in Sweden: A decrease in incidence and tumour stage, 1979 – 2001. Scandinavian Journal of Urology 47:4, pages 302-310.
Read now
Tau Pelant, Erik Højkjær Larsen, Lars Lund, Michael Borre, Rune Erichsen, Mette Nørgaard & Jacob Bonde Jacobsen. (2011) Survival of patients with kidney cancer in central and northern Denmark, 1998–2009. Clinical Epidemiology 3:sup1, pages 53-58.
Read now
Lars Lund, R Erichsen, M Nørgaard, E H Larsen, M Borre & J Jacobsen. (2011) Survival of invasive bladder cancer patients, 1998–2009; a central and northern Denmark population-based cohort study. Clinical Epidemiology 3:sup1, pages 47-51.
Read now
Hans H. Storm, Gerda Engholm, Timo Hakulinen, Laufey Tryggvadóttir, Åsa Klint, Mette Gislum, Anne Mette T. Kejs & Freddie Bray. (2010) Survival of patients diagnosed with cancer in the Nordic countries up to 1999–2003 followed to the end of 2006. A critical overview of the results. Acta Oncologica 49:5, pages 532-544.
Read now
Gerda Engholm, Mette Gislum, Freddie Bray & Timo Hakulinen. (2010) Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncologica 49:5, pages 545-560.
Read now

Articles from other publishers (11)

Heidi Amalie Rosendahl Jensen, Trine Allerslev Horsbøl, Lau Caspar Thygesen, Michael Davidsen, Anne Illemann Christensen & Ola Ekholm. (2023) Variations in the agreement of self‐reported cancer: A Danish nationwide study. International Journal of Cancer 154:2, pages 217-225.
Crossref
Kari Hemminki, Asta Försti, Akseli Hemminki, Börje Ljungberg & Otto Hemminki. (2022) Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years. PLOS ONE 17:1, pages e0261124.
Crossref
Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Asta Försti, Otto Hemminki & Kari Hemminki. (2021) Bladder and upper urinary tract cancers as first and second primary cancers. Cancer Reports 4:6.
Crossref
Anne Cowppli-Bony, Marc Colonna, Karine Ligier, Valérie Jooste, Gautier Defossez, Alain Monnereau, Brice Amadeo, Patrick Arveux, Isabelle Baldi, Simona Bara, Anne-Marie Bouvier, Véronique Bouvier, Jacqueline Clavel, Marc Colonna, Gaëlle Coureau, Anne Cowppli-Bony, Tania Dalmeida, Laetitia Daubisse-Marliac, Gautier Defossez, Patricia Delafosse, Jacqueline Deloumeaux, Pascale Grosclaude, Anne-Valérie Guizard, Clarisse Joachim, Brigitte Lacour, Bénédicte Lapôtre-Ledoux, Emilie Marrer, Marc Maynadié, Florence Molinié, Alain Monnereau, Jean-Baptiste Nousbaum, Juliette Plenet, Sandrine Plouvier, Camille Pouchieu, Michel Robaszkiewicz, Claire Schvartz, Brigitte Trétarre, Xavier Troussard, Michel Velten & Anne-Sophie Woronoff. (2019) Épidémiologie descriptive des cancers en France métropolitaine : incidence, survie et prévalence. Bulletin du Cancer 106:7-8, pages 617-634.
Crossref
Ray C. J. Hsu, Matthew Barclay, Molly A. Loughran, Georgios Lyratzopoulos, Vincent J. Gnanapragasam & James N. Armitage. (2018) Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010. BJU International 122:4, pages 599-609.
Crossref
Bent Storbjerg & Frede Donskov. (2018) Living with Advanced Kidney Cancer and Treatment with Cabozantinib: Through the Eyes of the Patient and the Physician. Oncology and Therapy 6:1, pages 1-7.
Crossref
Kishor Hadkhale, Jan Ivar Martinsen, Elisabete Weiderpass, Kristina Kjaerheim, Elsebeth Lynge, Pär Sparen, Laufey Tryggvadottir & Eero Pukkala. (2016) Occupation and Risk of Bladder Cancer in Nordic Countries. Journal of Occupational & Environmental Medicine 58:8, pages e301-e307.
Crossref
Tianhui Chen, Mahdi Fallah, Kristina Sundquist, Hao Liu & Kari Hemminki. (2014) Risk of subsequent cancers in renal cell carcinoma survivors with a family history. European Journal of Cancer 50:12, pages 2108-2118.
Crossref
K. Innos, A. Baburin & T. Aareleid. (2014) Cancer patient survival in Estonia 1995–2009: Time trends and data quality. Cancer Epidemiology 38:3, pages 253-258.
Crossref
X. Rébillard, P. Grosclaude, N. Leone, M. Velten, G. Coureau, A. Villers, J. Irani, T. Lebret, J. Rigaud, C. Pfister, J.-J. Patard, P. Richaud, L. Salomon, P. Coloby & M. Soulié. (2013) Projection de l’incidence et de la mortalité par cancer urologique en France en 2012. Progrès en Urologie 23, pages S57-S65.
Crossref
Isabelle Soerjomataram, Joannie Lortet-Tieulent, Jacques Ferlay, David Forman, Colin Mathers, D Maxwell Parkin & Freddie Bray. (2012) Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Medical Research Methodology 12:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.